News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Synteract, Inc. Announces New Vice President Of Medical And Regulatory Affairs



10/19/2005 5:10:06 PM

SAN DIEGO, Sept. 13 /PRNewswire/ -- Dr. Marilyn R. Carlson has joined Synteract as the Vice President of Medical & Regulatory Affairs, providing senior executive medical and regulatory guidance to the Company's clients.

Dr. Carlson is a graduate of Harvard (D.M.D.) and Case Western Reserve University (M.D.). She completed Internal Medicine at the Cleveland Clinic and is certified in Regulatory Affairs.

"We are fortunate to have a person of Dr. Carlson's caliber join our Organization. She brings over 13 years of pharmaceutical field experience to Synteract having worked across multiple therapeutic areas in the biotechnology, pharmaceutical, pharmacogenomic, medical device and managed care industries," said Ellen Morgan, President and Chief Executive Officer of Synteract, Inc. "Her knowledge and expertise in Medical, Regulatory and Clinical Affairs will be a valuable resource for Synteract's rapid growth and will expand the medical and regulatory services Synteract provides for their clients, particularly in early phase studies and overall strategic clinical program planning."

Dr. Carlson was previously with Procter & Gamble, XOMA, ISTA Pharmaceuticals and Prometheus Laboratories. She is President of entreMeDica, Inc., a medical consulting company.

About Synteract Inc.

Established in 1995, Synteract is a privately held, full-service contract research organization, dedicated to meeting the various needs of biotechnology, biomedical, pharmaceutical, and drug industry firms. Based in Carlsbad, CA, with a branch office in Pennsylvania, the Company provides expertise in a wide range of therapeutic areas and maintains a wealth of knowledge in oncology, ophthalmology, HIV, sexual dysfunction, cardiovascular disease, and pain. Since 2000, it has been a key development shop for web, wireless and voice data solutions that speed the completion of clinical trials and assist in access to clinical trials information. This includes technologies such as electronic data capture (EDC), interactive voice response systems (IVRS), and automated safety tracking and reporting. For information, please visit us at or call (760) 268.8200. http://www.synteract.com/

For more information please contact: Ellen Morgan, +1-760-268-8200 emorgan@synteract.com.

Synteract Inc.

CONTACT: Ellen Morgan of Synteract Inc, +1-760-268-8200emorgan@synteract.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES